Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids

By Jianu Constantin S.   Fossmark Reidar   Syversen Unni   Hauso ØØyvind   Fykse Vidar   Waldum Helge L.  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 4, 2011-04 ,pp. : 456-463

Informa Healthcare

Access to resources Recommend Favorite

Optimizing Somatostatin Analog Therapy in Acromegaly: Long-Acting Formulations

By Gilroy J.J.  

Treatments in Endocrinology, Vol. 1, Iss. 3, 2002-03 ,pp. : 149-154

Adis International

Access to resources Recommend Favorite

Long-acting octreotide in the treatment of diarrhea after pelvic pouch surgery

By Gullichsen R.  

Techniques in Coloproctology, Vol. 10, Iss. 4, 2006-12 ,pp. : 346-349

Springer Publishing Company

Access to resources Recommend Favorite

Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis

By Omata Fumio   Deshpande Gautam   Tokuda Yasuharu   Takahashi Osamu   Ohde Sachiko   Carr-Locke David   Jacobs Joshua   Mine Tetsuya   Fukui Tsuguya  

Journal of Gastroenterology, Vol. 45, Iss. 8, 2010-08 ,pp. : 885-895

Springer Publishing Company

Access to resources Recommend Favorite

Clinical experience with Sandostatin LAR ( R) in patients with acromegaly

By Heijckmann C.A.   Menheere P.P.C.A.   Sels J.-P.J.E.   Beuls E.A.M.   Wolffenbuttel B.H.R.  

The Netherlands Journal of Medicine, Vol. 59, Iss. 6, 2001-12 ,pp. : 286-291

Elsevier

Access to resources Recommend Favorite